Proteomics of human plasma: A criticalcomparison of analytical workflows in terms ofeffort, throughput and outcome

EuPA Open Proteomics

Volumn 1, Issue , 2013, Pages 8-16

  Dayon, Loïc ^a   Kussmann, Martin ^a,b,c  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b EPFL   (Switzerland)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Biomarker; Blood; Diagnosis; Liquid chromatography; Mass spectrometry; Shotgun proteomicsa

Indexed keywords

BIOLOGICAL MARKER; PLASMA PROTEIN; PROTEOME;

ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; FEASIBILITY STUDY; HUMAN; INTERMETHOD COMPARISON; MASS SPECTROMETRY; PLASMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEOMICS; QUANTITATIVE ANALYSIS; REVERSED PHASE LIQUID CHROMATOGRAPHY; WORKFLOW; ALKYLATION; ANALYTIC METHOD; FRACTIONATION; PLASMA CHARACTERISTICS; PROTEIN DEGRADATION; PROTEIN PURIFICATION; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; TAXONOMY;

EID: 84884572991     PISSN: 22129685     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euprot.2013.08.001     Document Type: Article

References (29)

1. Anderson NL, Anderson NG. The human plasma proteome:history, character, and diagnostic prospects. Mol CellProteomics 2002;1:845-67.
2. Anderson NL. The clinical plasma proteome: a survey ofclinical assays for proteins in plasma and serum. Clin Chem2010;56:177-85.
3. Whiteaker JR, Lin C, Kennedy J, Hou L, Trute M, Sokal I, et al.A targeted proteomics-based pipeline for verification ofbiomarkers in plasma. Nat Biotechnol 2011;29:625-34.
4. Whiteaker JR, Zhang H, Eng JK, Fang R, Piening BD, Feng LC,et al. Head-to-head comparison of serum fractionationtechniques. J Proteome Res 2007;6:828-36.
5. Qian WJ, Kaleta DT, Petritis BO, Jiang H, Liu T, Zhang X, et al.Enhanced detection of low abundance human plasmaproteins using a tandem IgY12-SuperMix immunoaffinityseparation strategy. Mol Cell Proteomics 2008;7:1963-73.
6. Schiess R, Wollscheid B, Aebersold R. Targeted proteomicstrategy for clinical biomarker discovery. Mol Oncol2009;3:33-44.
7. Shuford CM, Hawkridge AM, Burnett JC, Muddiman DC.Utilizing spectral counting to quantitatively characterizetandem removal of abundant proteins (TRAP) in humanplasma. Anal Chem 2010;82:10179-85.
8. Tu C, Rudnick PA, Martinez MY, Cheek KL, Stein SE, SlebosRJC, et al. Depletion of abundant plasma proteins andlimitations of plasma proteomics. J Proteome Res2010;9:4982-91.
9. Gilar M, Olivova P, Daly AE, Gebler JC. Two-dimensionalseparation of peptides using RP-RP-HPLC system withdifferent pH in first and second separation dimensions. J SepSci 2005;28:1694-703.
10. Desjardins P, Hansen JB, Allen M. Microvolumespectrophotometric and fluorometric determination ofprotein concentration. Curr Protein Pept Sci 2009,3.10.1-3.10.6.
11. Dayon L, Sonderegger B, Kussmann M. Combination ofgas-phase fractionation and MS 3 acquisition modes forrelative protein quantification with isobaric tagging. JProteome Res 2012;11:5081-9.
12. Dayon L, Pasquarello C, Hoogland C, Sanchez JC, Scherl A.Combining low- and high-energy tandem mass spectra foroptimized peptide quantification with isobaric tags. JProteom 2010;73:769-77.
13. Bradford MM. A rapid and sensitive method for thequantitation of microgram quantities of protein utilizing theprinciple of protein-dye binding. Anal Biochem1976;72:248-54.
14. Farrah T, Deutsch EW, Omenn GS, Campbell DS, Sun Z, BletzJA, et al. A high-confidence human plasma proteomereference set with estimated concentrations in PeptideAtlas.Mol Cell Proteomics 2011;10:1.
15. Christoforou AL, Lilley KS. Isobaric tagging approaches inquantitative proteomics: the ups and downs. Anal BioanalChem 2012;404:1029-37.
16. Engmann O, Campbell J, Ward M, Giese KP, Thompson AJ.Comparison of a protein-level and peptide-level labelingstrategy for quantitative proteomics of synaptosomes usingisobaric tags. J Proteome Res 2010;9:2725-33.
17. McAlister GC, Huttlin EL, Haas W, Ting L, Jedrychowski MP,Rogers JC, et al. Increasing the multiplexing capacity ofTMTs using reporter ion isotopologues with isobaric masses.Anal Chem 2012;84:7469-78.
18. Werner T, Becher I, Sweetman G, Doce C, Savitski MM,Bantscheff M. High-resolution enabled TMT 8-plexing. AnalChem 2012;84:7188-94.
19. Dayon L, Hainard A, Licker V, Turck N, Kuhn K, HochstrasserDF, et al. Relative quantification of proteins in humancerebrospinal fluids by MS/MS using 6-plex isobaric tags.Anal Chem 2008;80:2921-31.
20. Hagman C, Ramström M, Jansson M, James P, Håkansson P,Bergquist J. Reproducibility of tryptic digestion investigatedby quantitative fourier transform ion cyclotron resonancemass spectrometry. J Proteome Res 2005;4:394-9.
21. Pernemalm M, Orre LM, Lengqvist J, Wikström P, LewensohnR, Lehtiö J. Evaluation of three principally different intactprotein prefractionation methods for plasma biomarkerdiscovery. J Proteome Res 2008;7:2712-22.
22. Smith MPW, Wood SL, Zougman A, Ho JTC, Peng J, Jackson D,et al. A systematic analysis of the effects of increasingdegrees of serum immunodepletion in terms of depth ofcoverage and other key aspects in top-down and bottom-upproteomic analyses. Proteomics 2011;11:2222-35.
23. Yang F, Shen Y, Camp Ii DG, Smith RD. High-pHreversed-phase chromatography with fractionconcatenation for 2D proteomic analysis. Expert RevProteom 2012;9:129-34.
24. Roche S, Tiers L, Provansal M, Seveno M, Piva M-T, Jouin P,et al. Depletion of one, six, twelve or twenty major bloodproteins before proteomic analysis: the more the better. JProteom 2009;72:945-51.
25. Hwang SJ, Ballantyne CM, Sharrett AR, Smith LC, Davis CE,Gotto Jr AM, et al. Circulating adhesion molecules VCAM-1,ICAM-1, and E-selectin in carotid atherosclerosis andincident coronary heart disease cases: The AtherosclerosisRisk In Communities (ARIC) study. Circulation1997;96:4219-25.
26. Kunz AB, Kraus J, Young P, Reuss R, Wipfler P, Oschmann P,et al. Biomarkers of inflammation and endothelialdysfunction in stroke with and without sleep apnea.Cerebrovasc Dis 2012;33:453-60.
27. Volcik KA, Ballantyne CM, Hoogeveen R, Folsom AR,Boerwinkle E. Intercellular adhesion molecule-1 G241Rpolymorphism predicts risk of incident ischemic stroke:Atherosclerosis risk in communities study. Stroke2010;41:1038-40.
28. Dayon L, Turck N, García-Berrocoso T, Walter N, Burkhard PR,Vilalta A, et al. Brain extracellular fluid protein changes inacute stroke patients. J Proteome Res 2011;10:1043-51.
29. Lescuyer P, Gandini A, Burkhard PR, Hochstrasser DF,Sanchez JC. Prostaglandin D2 synthase and itspost-translational modifications in neurological disorders. Electrophoresis 2005;26:4563-70.